Tags

Type your tag names separated by a space and hit enter

Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee.
J Rheumatol 1988; 15(12):1833-40JR

Abstract

Within the context of a double blind randomized controlled parallel trial of 2 nonsteroidal antiinflammatory drugs, we validated WOMAC, a new multidimensional, self-administered health status instrument for patients with osteoarthritis of the hip or knee. The pain, stiffness and physical function subscales fulfil conventional criteria for face, content and construct validity, reliability, responsiveness and relative efficiency. WOMAC is a disease-specific purpose built high performance instrument for evaluative research in osteoarthritis clinical trials.

Authors+Show Affiliations

University of Western Ontario, London, Canada.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

3068365

Citation

Bellamy, N, et al. "Validation Study of WOMAC: a Health Status Instrument for Measuring Clinically Important Patient Relevant Outcomes to Antirheumatic Drug Therapy in Patients With Osteoarthritis of the Hip or Knee." The Journal of Rheumatology, vol. 15, no. 12, 1988, pp. 1833-40.
Bellamy N, Buchanan WW, Goldsmith CH, et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15(12):1833-40.
Bellamy, N., Buchanan, W. W., Goldsmith, C. H., Campbell, J., & Stitt, L. W. (1988). Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. The Journal of Rheumatology, 15(12), pp. 1833-40.
Bellamy N, et al. Validation Study of WOMAC: a Health Status Instrument for Measuring Clinically Important Patient Relevant Outcomes to Antirheumatic Drug Therapy in Patients With Osteoarthritis of the Hip or Knee. J Rheumatol. 1988;15(12):1833-40. PubMed PMID: 3068365.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. AU - Bellamy,N, AU - Buchanan,W W, AU - Goldsmith,C H, AU - Campbell,J, AU - Stitt,L W, PY - 1988/12/1/pubmed PY - 1988/12/1/medline PY - 1988/12/1/entrez SP - 1833 EP - 40 JF - The Journal of rheumatology JO - J. Rheumatol. VL - 15 IS - 12 N2 - Within the context of a double blind randomized controlled parallel trial of 2 nonsteroidal antiinflammatory drugs, we validated WOMAC, a new multidimensional, self-administered health status instrument for patients with osteoarthritis of the hip or knee. The pain, stiffness and physical function subscales fulfil conventional criteria for face, content and construct validity, reliability, responsiveness and relative efficiency. WOMAC is a disease-specific purpose built high performance instrument for evaluative research in osteoarthritis clinical trials. SN - 0315-162X UR - https://www.unboundmedicine.com/medline/citation/3068365/Validation_study_of_WOMAC:_a_health_status_instrument_for_measuring_clinically_important_patient_relevant_outcomes_to_antirheumatic_drug_therapy_in_patients_with_osteoarthritis_of_the_hip_or_knee_ L2 - https://ClinicalTrials.gov/search/term=3068365 [PUBMED-IDS] DB - PRIME DP - Unbound Medicine ER -